Firm
After five IP partners left the firm for White & Case, the IP market could yet see more laterals
Paul Chapman and Robert Lind, who are retiring from Marks & Clerk after 30-year careers, discuss workplace loyalty, client care, and why we should be optimistic but cautious about AI
UK firm Shakespeare Martineau, which secured victory for the Triton shower brand at the Court of Appeal, explains how it navigated a tricky test regarding patent claim scopes
The firm’s managing partner said the city is an ‘exciting hub of ideas and innovation’
Recently published Special Focus articles
Recently published Special Focus articles
-
Sponsored by Gün and PartnersUğur Aktekin, Selin Bilik, and Bilge Ayperi Kemer of Gün + Partners examine a ruling confirming that trademark distinctiveness and reputation can prove bad faith under Turkish law -
Sponsored by CASThe emerging trends and strategic approaches in intellectual property search and analytics are outlined in a CAS article that suggests how chemical industry stakeholders can strengthen patent programmes, empower R&D teams, and gain competitive insight
-
Sponsored by Maiwald Intellectual PropertySenior Maiwald lawyers outline the strategy behind the firm’s recognition as EPO Proceedings Firm of the Year at the Managing IP EMEA Awards 2025 and discuss key developments in the European intellectual property space
-
Sponsored by Bugnion SpAVieri Canepele of Bugnion SpA examines a landmark Italian Supreme Court ruling on whether a patent co-owner may exploit a jointly owned invention without consent from fellow rights holders
-
Sponsored by Liu, Shen & AssociatesGuanyang Yao of Liu, Shen & Associates reviews several Chinese court rulings on standard-essential patent disputes, including Panasonic v Oppo, and the growing judicial focus on mediation and comparable licences over top-down rate setting
-
Sponsored by Wanhuida Intellectual PropertyWu Xiaohui of Wanhuida Intellectual Property examines how a recent CNIPA decision reinforces the need for a holistic inventive step assessment when evaluating pharmaceutical combination formulations involving active ingredients that are chemically reactive
